Revelation Capital Management reveals latest 13F holdings
Revelation Capital Management discloses its latest 13F report, highlighting key investments in biotech firms Artiva Biotherapeutics and Obsidian Therapeutics.
Aurora Innovation removes warrants from Nasdaq trading
Aurora Innovation, Inc. has removed its warrants from trading on the Nasdaq, signaling a shift in its capital strategy.
Morgan Stanley Finance LLC Files Pricing Supplement for Securities
Morgan Stanley Finance LLC has filed a pricing supplement for structured investments, showcasing their focus on innovative financial products.
Chandrasekhar Rao Jadcherla Files to Sell 6,000 Shares
Chandrasekhar Rao Jadcherla has filed to sell 6,000 shares of EGAIN Corporation, valued at approximately $35,421, reflecting ongoing stock option exercises.
Moshkevich Solomon Files to Sell 3,000 Shares of Natera, Inc.
Moshkevich Solomon files to sell 3,000 shares of Natera, Inc., indicating ongoing stock management strategies in the medical laboratories sector.
ONESPAWORLD HOLDINGS reports insider share sale
ONESPAWORLD HOLDINGS Ltd reports a sale of 10,000 shares by affiliate Mindy Beth Heyer, valued at approximately $306,896.
Apollo S3 Private Markets Fund Completes Tender Offer
Apollo S3 Private Markets Fund repurchases over 154,000 shares in a recent tender offer, reflecting strategic capital management.
HealthPAT Inc. announces new private offering to raise capital
HealthPAT Inc. files for a new private offering under Rule 506(b) to raise $150,000, signaling a strategic shift in its funding approach.
Morgan Stanley Files Free Writing Prospectus for New Securities
Morgan Stanley has filed a prospectus for new securities linked to major indices, enhancing its product offerings in the competitive brokerage industry.
Montchanin Asset Management files 13F-HR report for Q2 2025
Montchanin Asset Management's latest 13F-HR filing reveals key holdings and investment strategies as of June 30, 2025.
Burke & Herbert Bank Reports $402.5M in Latest 13F-HR Filing
Burke & Herbert Bank & Trust Co. filed a 13F-HR, reporting $402.5 million in holdings as of September 30, 2026, reflecting its investment strategies.
Citigroup Global Markets files preliminary term sheet for new securities
Citigroup Global Markets Holdings Inc. files a preliminary term sheet for new securities linked to major indices, signaling strategic growth in the brokerage sector.
NorthStrive Acquisition Corp I. to Merge with Nuclea Energy Inc.
NorthStrive Acquisition Corp I. announces a merger with Nuclea Energy Inc., a significant move in the SPAC industry, enhancing its market position.
Brophy Michael Burkes files to sell shares of Natera, Inc.
Michael Burkes Brophy files to sell 313 shares of Natera, Inc., valued at $129,675, following multiple recent transactions.
Boggs Michael Huff files 13F Notice, signals investment change
Boggs Michael Huff has filed a 13F Notice, indicating a potential shift in its investment strategy and collaboration with Revelation Capital Management.
Narragansett Bancorp sees majority stake acquisition
Narragansett Bancorp announces a majority stake acquisition by Narragansett Financial Corporation, marking a significant change in its ownership structure.
Maze Therapeutics officer sells 34,501 shares in Form 144
Maze Therapeutics files Form 144 for the sale of 34,501 shares by an officer, reflecting ongoing insider trading activity in the biological products sector.
Morgan Stanley Files Free Writing Prospectus for New Offering
Morgan Stanley's latest filing reveals a new securities offering aimed at attracting investors, highlighting competition in the security brokerage industry.
IZEA CEO Patrick Venetucci Reports Stock Transactions
Patrick James Venetucci, CEO of IZEA Worldwide, Inc., disclosed stock transactions in a recent SEC filing, highlighting his commitment to the company.
Xu Shanshan acquires stock options and RSUs at Bambusa
Xu Shanshan, CEO of Bambusa Therapeutics, reports acquisition of stock options and RSUs, signaling commitment to leadership and company growth.